Identification of prognostic factors predicting outcome in Hodgkin's lymphoma patients relapsing after autologous stem cell transplantation†
Background - High-dose chemotherapy followed by autologous stem cell transplantation (ASCT) is the standard of care for patients with relapsed Hodgkin's lymphoma (HL). However, there is currently little information on the predictors of outcome for patients whose disease recurs after ASCT. - Met...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
26 May 2013
|
| In: |
Annals of oncology
Year: 2013, Jahrgang: 24, Heft: 9, Pages: 2430-2434 |
| ISSN: | 1569-8041 |
| DOI: | 10.1093/annonc/mdt206 |
| Online-Zugang: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1093/annonc/mdt206 Verlag, lizenzpflichtig, Volltext: https://www.sciencedirect.com/science/article/pii/S0923753419369443 
|
| Verfasserangaben: | C. Martínez, C. Canals, B. Sarina, E.P. Alessandrino, D. Karakasis, A. Pulsoni, S. Sica, M. Trneny, J.A. Snowden, E. Kanfer, N. Milpied, A. Bosi, S. Guidi, C.A. de Souza, R. Willemze, R. Arranz, L. Jebavy, A. Hellmann, D. Sibon, R. Oneto, J.J. Luan, P. Dreger, L. Castagna, & A. Sureda, for the Lymphoma Working Party of the European Group for Blood and Marrow Transplantation (EBMT) and the Gruppo Italiano Trapianto di MidolloOsseo(GITMO) |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1761140663 | ||
| 003 | DE-627 | ||
| 005 | 20230426153105.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 210623s2013 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1093/annonc/mdt206 |2 doi | |
| 035 | |a (DE-627)1761140663 | ||
| 035 | |a (DE-599)KXP1761140663 | ||
| 035 | |a (OCoLC)1341416714 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Martínez, Carmen |e VerfasserIn |0 (DE-588)1156721709 |0 (DE-627)1019661607 |0 (DE-576)502392592 |4 aut | |
| 245 | 1 | 0 | |a Identification of prognostic factors predicting outcome in Hodgkin's lymphoma patients relapsing after autologous stem cell transplantation† |c C. Martínez, C. Canals, B. Sarina, E.P. Alessandrino, D. Karakasis, A. Pulsoni, S. Sica, M. Trneny, J.A. Snowden, E. Kanfer, N. Milpied, A. Bosi, S. Guidi, C.A. de Souza, R. Willemze, R. Arranz, L. Jebavy, A. Hellmann, D. Sibon, R. Oneto, J.J. Luan, P. Dreger, L. Castagna, & A. Sureda, for the Lymphoma Working Party of the European Group for Blood and Marrow Transplantation (EBMT) and the Gruppo Italiano Trapianto di MidolloOsseo(GITMO) |
| 264 | 1 | |c 26 May 2013 | |
| 300 | |a 5 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 23.06.2021 | ||
| 520 | |a Background - High-dose chemotherapy followed by autologous stem cell transplantation (ASCT) is the standard of care for patients with relapsed Hodgkin's lymphoma (HL). However, there is currently little information on the predictors of outcome for patients whose disease recurs after ASCT. - Methods - Five hundred and eleven adult patients with relapsed HL after ASCT from EBMT-GITMO databases were reviewed. - Results - Treatments administered following ASCT failure included conventional chemotherapy and/or radiotherapy in 294 (64%) patients, second ASCT in 35 (8%), and alloSCT in 133 (29%). After a median follow-up of 49 months, overall survival (OS) was 32% at 5 years. Independent risk factors for OS were early relapse (<6 months) after ASCT, stage IV, bulky disease, poor performance status (PS), and age ≥50 years at relapse. For patients with no risk factors OS at 5 years was 62% compared with 37% and 12% for those having 1 and ≥2 factors, respectively. This score was also predictive for outcome in each group of rescue treatment after ASCT failure. - Conclusion(s) - Early relapse, stage IV, bulky disease, poor PS, and age ≥50 years at ASCT failure are relevant factors for outcome that may help to understand the results of different therapeutic approaches. | ||
| 650 | 4 | |a autologous stem cell transplantation | |
| 650 | 4 | |a Hodgkin's lymphoma | |
| 650 | 4 | |a relapse | |
| 700 | 1 | |a Canals, C. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Sarina, B. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Alessandrino, E. P. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Karakasis, D. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Pulsoni, A. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Sica, S. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Trneny, M. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Snowden, J. A. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Kanfer, E. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Milpied, N. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Bosi, A. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Guidi, S. |e VerfasserIn |4 aut | |
| 700 | 1 | |a de Souza, C. A. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Willemze, R. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Arranz, R. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Jebavy, L. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Hellmann, A. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Sibon, D. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Oneto, R. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Luan, J. J. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Dreger, Peter |e VerfasserIn |0 (DE-588)1028891881 |0 (DE-627)732699894 |0 (DE-576)376320966 |4 aut | |
| 700 | 1 | |a Castagna, L. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Sureda, A. |e VerfasserIn |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Annals of oncology |d Amsterdam [u.a.] : Elsevier, 1990 |g 24(2013), 9 vom: Sept., Seite 2430-2434 |h Online-Ressource |w (DE-627)320428796 |w (DE-600)2003498-2 |w (DE-576)098134345 |x 1569-8041 |7 nnas |a Identification of prognostic factors predicting outcome in Hodgkin's lymphoma patients relapsing after autologous stem cell transplantation† |
| 773 | 1 | 8 | |g volume:24 |g year:2013 |g number:9 |g month:09 |g pages:2430-2434 |g extent:5 |a Identification of prognostic factors predicting outcome in Hodgkin's lymphoma patients relapsing after autologous stem cell transplantation† |
| 856 | 4 | 0 | |u https://doi.org/10.1093/annonc/mdt206 |x Verlag |x Resolving-System |z lizenzpflichtig |3 Volltext |
| 856 | 4 | 0 | |u https://www.sciencedirect.com/science/article/pii/S0923753419369443 |x Verlag |z lizenzpflichtig |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20210623 | ||
| 993 | |a Article | ||
| 994 | |a 2013 | ||
| 998 | |g 1028891881 |a Dreger, Peter |m 1028891881:Dreger, Peter |d 910000 |d 910100 |e 910000PD1028891881 |e 910100PD1028891881 |k 0/910000/ |k 1/910000/910100/ |p 22 | ||
| 999 | |a KXP-PPN1761140663 |e 3940996793 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"name":{"displayForm":["C. Martínez, C. Canals, B. Sarina, E.P. Alessandrino, D. Karakasis, A. Pulsoni, S. Sica, M. Trneny, J.A. Snowden, E. Kanfer, N. Milpied, A. Bosi, S. Guidi, C.A. de Souza, R. Willemze, R. Arranz, L. Jebavy, A. Hellmann, D. Sibon, R. Oneto, J.J. Luan, P. Dreger, L. Castagna, & A. Sureda, for the Lymphoma Working Party of the European Group for Blood and Marrow Transplantation (EBMT) and the Gruppo Italiano Trapianto di MidolloOsseo(GITMO)"]},"person":[{"family":"Martínez","display":"Martínez, Carmen","given":"Carmen","role":"aut"},{"family":"Canals","role":"aut","given":"C.","display":"Canals, C."},{"role":"aut","given":"B.","display":"Sarina, B.","family":"Sarina"},{"given":"E. P.","role":"aut","display":"Alessandrino, E. P.","family":"Alessandrino"},{"family":"Karakasis","given":"D.","role":"aut","display":"Karakasis, D."},{"family":"Pulsoni","display":"Pulsoni, A.","role":"aut","given":"A."},{"display":"Sica, S.","role":"aut","given":"S.","family":"Sica"},{"family":"Trneny","given":"M.","role":"aut","display":"Trneny, M."},{"role":"aut","given":"J. A.","display":"Snowden, J. A.","family":"Snowden"},{"role":"aut","given":"E.","display":"Kanfer, E.","family":"Kanfer"},{"family":"Milpied","display":"Milpied, N.","role":"aut","given":"N."},{"family":"Bosi","display":"Bosi, A.","given":"A.","role":"aut"},{"display":"Guidi, S.","given":"S.","role":"aut","family":"Guidi"},{"role":"aut","given":"C. A.","display":"de Souza, C. A.","family":"de Souza"},{"display":"Willemze, R.","given":"R.","role":"aut","family":"Willemze"},{"display":"Arranz, R.","given":"R.","role":"aut","family":"Arranz"},{"display":"Jebavy, L.","given":"L.","role":"aut","family":"Jebavy"},{"family":"Hellmann","role":"aut","given":"A.","display":"Hellmann, A."},{"family":"Sibon","given":"D.","role":"aut","display":"Sibon, D."},{"family":"Oneto","display":"Oneto, R.","given":"R.","role":"aut"},{"role":"aut","given":"J. J.","display":"Luan, J. J.","family":"Luan"},{"family":"Dreger","display":"Dreger, Peter","role":"aut","given":"Peter"},{"family":"Castagna","given":"L.","role":"aut","display":"Castagna, L."},{"family":"Sureda","display":"Sureda, A.","given":"A.","role":"aut"}],"origin":[{"dateIssuedKey":"2013","dateIssuedDisp":"26 May 2013"}],"recId":"1761140663","type":{"media":"Online-Ressource","bibl":"article-journal"},"note":["Gesehen am 23.06.2021"],"relHost":[{"part":{"issue":"9","extent":"5","pages":"2430-2434","text":"24(2013), 9 vom: Sept., Seite 2430-2434","year":"2013","volume":"24"},"language":["eng"],"title":[{"title_sort":"Annals of oncology","title":"Annals of oncology","subtitle":"official journal of the European Society for Medical Oncology"}],"pubHistory":["1.1990 -"],"type":{"media":"Online-Ressource","bibl":"periodical"},"origin":[{"publisherPlace":"Amsterdam [u.a.] ; Dordrecht [u.a.] ; Oxford","publisher":"Elsevier ; Kluwer ; Oxford Univ. Press","dateIssuedDisp":"1990-","dateIssuedKey":"1990"}],"recId":"320428796","corporate":[{"role":"isb","display":"European Society for Medical Oncology"}],"note":["Gesehen am 12.11.20","Ungezählte Beil.: Supplement"],"disp":"Identification of prognostic factors predicting outcome in Hodgkin's lymphoma patients relapsing after autologous stem cell transplantation†Annals of oncology","physDesc":[{"extent":"Online-Ressource"}],"id":{"eki":["320428796"],"issn":["1569-8041"],"zdb":["2003498-2"]}}],"physDesc":[{"extent":"5 S."}],"id":{"doi":["10.1093/annonc/mdt206"],"eki":["1761140663"]},"language":["eng"],"title":[{"title_sort":"Identification of prognostic factors predicting outcome in Hodgkin's lymphoma patients relapsing after autologous stem cell transplantation†","title":"Identification of prognostic factors predicting outcome in Hodgkin's lymphoma patients relapsing after autologous stem cell transplantation†"}]} | ||
| SRT | |a MARTINEZCAIDENTIFICA2620 | ||